sarpogrelate has been researched along with Neuralgia, Sciatic in 3 studies
sarpogrelate: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty patients with sciatica due to L4-5 or L5-S1 disc herniation were randomly allocated to treatment with the 5-HT2A inhibitor (sarpogrelate 300 mg/day) or nonsteroidal antiinflammatory drugs (NSAIDs; diclofenac 75 mg/day)." | 5.11 | New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial. ( Hashimoto, T; Kanayama, M; Oha, F; Shigenobu, K; Yamane, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, M | 1 |
| Kanayama, M | 2 |
| Hashimoto, T | 2 |
| Shigenobu, K | 2 |
| Yamane, S | 2 |
| Oha, F | 1 |
2 trials available for sarpogrelate and Neuralgia, Sciatic
| Article | Year |
|---|---|
The NMatrix, a new method of presenting statistics, displays the characteristics of medicines with similar effects used in the treatment of lumbar spinal stenosis concisely and clearly, facilitating the selection of appropriate medications.
Topics: Aged; Aged, 80 and over; alpha-Cyclodextrins; Alprostadil; Decision Making; Eicosapentaenoic Acid; E | 2015 |
New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Autonomic Nerve Block; Diclofenac; Epidural Space; F | 2005 |
1 other study available for sarpogrelate and Neuralgia, Sciatic
| Article | Year |
|---|---|
Efficacy of serotonin receptor blocker for symptomatic lumbar disc herniation.
Topics: Adult; Female; Humans; Hypesthesia; Intervertebral Disc Displacement; Low Back Pain; Magnetic Resona | 2003 |